JILIN PROVINCE HUINAN CHANGLONG BIO-PHARMACY COMPANY LIMITED Jilin Province Huinan Changlong Bio-pharmacy Company Limited Stock
Equities
8049
CNE100000130
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.84 HKD | +2.22% |
|
+1.66% | +12.20% |
| Sales 2022 | 842M 116M 910M | Sales 2023 | 842M 116M 910M | Capitalization | 835M 115M 903M |
|---|---|---|---|---|---|
| Net income 2022 | 194M 26.78M 210M | Net income 2023 | 148M 20.43M 160M | EV / Sales 2022 | -0.74 x |
| Net cash position 2022 | 1.05B 145M 1.13B | Net cash position 2023 | 578M 79.74M 625M | EV / Sales 2023 | 0.31 x |
| P/E ratio 2022 |
2.22
x | P/E ratio 2023 |
5.63
x | Employees | 848 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 23.02% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.22% | ||
| 1 week | +1.66% | ||
| Current month | +5.75% | ||
| 1 month | +3.37% | ||
| 3 months | +13.58% | ||
| 6 months | +43.75% | ||
| Current year | +12.20% |
1 week
1.80
1.85
1 month
1.431.85
Current year
1.431.95
1 year
1.072.05
3 years
0.842.05
5 years
0.842.05
10 years
0.845.20
| Managers | Title | Age | Since |
|---|---|---|---|
Bao Gang Zhao
DFI | Director of Finance/CFO | 57 | 96-07-31 |
Hong Zhang
CHM | Chairman | 69 | 89-09-30 |
Xiang Fu Xu
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hong Zhang
CHM | Chairman | 69 | 89-09-30 |
Bao Gang Zhao
DFI | Director of Finance/CFO | 57 | 96-07-31 |
Jie Tian
BRD | Director/Board Member | 52 | 15-06-24 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 1.84 | +2.22% | 176,000 |
| 24-04-22 | 1.8 | 0.00% | 52,000 |
| 24-04-19 | 1.8 | -2.70% | 248,000 |
| 24-04-18 | 1.85 | +0.54% | 176,000 |
| 24-04-17 | 1.84 | +1.66% | 104,000 |
Delayed Quote Hong Kong S.E., April 23, 2024 at 04:09 am EDT
More quotes
Jilin Province Huinan Changlong Bio-pharmacy Company Limited is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products. Its products are mainly sold under the brand names of Changlong and Qing Tong. Its primary products include tablets, capsules, bulk drug, membrane, pills, bulk drug, powder for injection, lyophilized powder for injection, small volume parenteral solutions, sterile bulk drug and solution. The Company is also engaged in the trading of biochemical medicine through its subsidiaries. Its principal subsidiaries include Jilin Province Huinan Changlong Pharmacy Trading Company Limited and Jilin Province Medicinal Plants Trading Company Limited.
Sector
Pharmaceuticals
Calendar
2024-05-08
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +12.20% | 129M | |
| -2.68% | 85.68B | |
| +4.08% | 41.4B | |
| -25.35% | 28.22B | |
| +54.31% | 24.64B | |
| -4.52% | 16.98B | |
| -42.09% | 13.29B | |
| -17.77% | 11.66B | |
| -12.10% | 11.65B | |
| +0.75% | 8.18B |
- Stock Market
- Equities
- 8049 Stock
